Quick Answer
TG THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $79.15 million for the year ending 2025.
- TG THERAPEUTICS, INC. showed a decrease of -56.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from TG THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on February 27, 2026.
- XBRL data for this metric is available from 2009 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $79.15 million | Fiscal year 2024: $179.89 million | Fiscal year 2023: $92.93 million | Fiscal year 2022: $102.30 million | Fiscal year 2021: $298.89 million | Fiscal year 2020: $553.44 million | Fiscal year 2019: $112.64 million | Fiscal year 2018: $41.96 million | Fiscal year 2017: $56.72 million | Fiscal year 2016: $25.03 million | Fiscal year 2015: $55.06 million | Fiscal year 2014: $55.71 million | Fiscal year 2013: $40.49 million | Fiscal year 2012: $16.46 million | Fiscal year 2011: $9.75 million | Fiscal year 2011: $0.00 | Fiscal year 2010: $0.00 | Fiscal year 2009: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: